Award
NIH Reporter #1R37CA297078-01A1
Targeting non-genetic and genetic mechanisms to overcome drug resistance in acute myeloid leukemia
Recipient
Emory University, Atlanta
Award Amount
$639,859.00
Ceiling
$639,859.00
Awarded
April 28, 2026
Identifier
1R37CA297078-01A1
Research project awarded by the National Cancer Institute to study drug resistance in acute myeloid leukemia using genetic and non-genetic approaches, funded for approximately $639,859 over five years.
Description
The project involves research on drug resistance mechanisms in acute myeloid leukemia. The award is funded by the National Cancer Institute. The project includes multiple aims involving genetic and non-genetic clonal evolution, single-cell transcriptomics, and drug vulnerability testing. The project duration is from May 1, 2026, to April 30, 2031.